CURRICULUM VITAE Gerald Louis Andriole, Jr., M.D. Address ...

Grant Support:
PAST
Funding Agency:
Biomedical Research Support Grant, Washington University
Period: 1985
Grant Title:
The Effect of Pure 5-Alpha Reductase Applied Inhibitors on the Growth of
Human Androgen Responsive Genitourinary Tumors
Principal Investigator: Gerald L. Andriole, M.D.
Total Direct Costs: $9568
Percent of Effort: 5%
Funding Agency:
American Cancer Society
Period: 1986
Grant Title:
The Effect of Interleukin-2 and Lymphokine Activated Killer Cells on the
Development of Murine Bladder Tumors
Principal Investigator: Gerald L. Andriole, M.D.
Total Direct Costs: $10,000
Percent of Effort: 5%
Funding Agency:
American Foundation for Urologic Disease/National Kidney
Foundation Fellowship
Period: 1989
Grant Title:
Experimental Immunotherapy for Bladder Cancer
Principal Investigator: Gerald L. Andriole, M.D.
Total Direct Costs: $25,000
Percent of Effort: 5%
Funding Agency:
National Institutes of Health
Period: 1996-2000
Grant Title:
Medical Therapy in Benign Prostatic Hyperplasia: Supplement for Minority
Investigators
Total Direct Costs: $209,182
Funding Agency:
National Institute of Diabetes and Digestive and Kidney Diseases
Period: 1995-2002
Grant Title:
Medical Therapy in Benign Prostatic Hyperplasia (MTOPS): A Full Scale
Clinical Trial
Total Direct Costs: $1,409,363
Percent of Effort: 23%
CURRENT
Funding Agency:
National Cancer Institute
Period: 1992-2007
Grant Title:
Prostate, Lung, Colorectal & Ovarian Cancer Screening Study (N01-CN-25516)
Total Direct Costs: $33,541,622
Percent of Effort: 25%
Funding Agency:
National Institute of Diabetes and Digestive and Kidney Diseases
(U01-DK63825)
4